US Pharma MarketingMerck beats AstraZeneca to first approval for first PCSK9 pill
Merck Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA policy and drug approvals: What’s changing…
As in football, so in pharmaceuticals: the English have been beaten.
Merck has outpaced AstraZeneca in the race to get the first US approval for an oral form of a particular kind of cholesterol-lowering medication.
...
Source: Endpoints News